Table 1

Demographics of the 32 randomly assigned patients with type 2 diabetes, hypertension, and albuminuria and the 26 included in the final analysis

Total randomized populationIncluded in analysis
n3226
Age (years)60.3 ± 9.059.8 ± 9.2
Male (%)25 (78)20 (77)
Caucasian (%)32 (100)26 (100)
Height (cm)175 ± 9175 ± 10
Weight (kg)99.9 ± 20.6100.9 ± 21.4
BMI (kg/m2)32.3 ± 5.432.7 ± 5.5
A1C (%)8.1 ± 1.38.2 ± 1.3
Total cholesterol (mmol/l)3.7 ± 0.83.8 ± 0.8
Smoking108
CVD history41
Blood pressure medications before study inclusion (n)2.5 ± 0.82.3 ± 0.8
RAAS blocking treatment prior to study inclusion (n)3024
Baseline 24-h blood pressure (mmHg)*142/74 ± 12/8141/74 ± 12/7
Baseline UAER (mg/day)*307 (87–1,378)275 (103–1,088)
  • Data are means ±SD, n, or mean (range).

  • *Baseline was defined as day of randomization. Values from the placebo treatment period were used in end point analysis.